An Australian biotechnology company is establishing Vietnam’s first AI-driven hospital, the MedArmor AI Hospital, focusing on preventive care through early disease detection and virtual technologies. Located in Long An province, it aims to enhance healthcare access, reduce costs, and promote sustainability. Leveraging advanced AI for patient data analysis, it will streamline operations and improve clinician focus on patient care.
Wall Street’s Leaders and Laggards of 2024
2024 was a mixed year for biopharma stocks, with the iShares Biotechnology ETF and SPDR S&P Biotech ETF experiencing small decreases. Federal Reserve decisions caused
